KAN-004irColitisCentre Hospitalier de l’Université de MontréalKanvas Biosciencescolitis
…de l’Université de Montréal (CHUM), a phase I clinical trial of KAN-004 in patients with irColitis is planned to begin in Q4 2025.…
1articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: KAN-004 ×
KAN-004
This drug is selected. Its supporting articles are shown below.